Detalhe da pesquisa
1.
Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma.
Immunity
; 56(1): 180-192.e11, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36563676
2.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 402(10415): 1835-1847, 2023 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871608
3.
Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial.
BMC Med
; 22(1): 172, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650037
4.
Development and validation of robust metabolism-related gene signature in the prognostic prediction of hepatocellular carcinoma.
J Cell Mol Med
; 27(7): 1006-1020, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919714
5.
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients.
Cancer
; 129(4): 569-579, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541017
6.
Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis.
Hepatology
; 75(5): 1123-1138, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34435708
7.
An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer.
BMC Cancer
; 23(1): 193, 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849920
8.
The Antiangiogenic and Antitumor Effects of Scoparasin B in Non-Small-Cell Lung Cancer.
J Nat Prod
; 86(2): 368-379, 2023 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692021
9.
One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma.
BMC Med
; 20(1): 415, 2022 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36310160
10.
Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
Ann Surg Oncol
; 29(3): 2016-2029, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637058
11.
Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications.
BMC Cancer
; 22(1): 293, 2022 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305593
12.
Efficacy and safety of selexipag, an oral prostacyclin receptor agonist for the treatment of pulmonary hypertension: A meta-analysis.
Pulm Pharmacol Ther
; 72: 102100, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856365
13.
The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
Int J Hyperthermia
; 39(1): 688-696, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35469522
14.
Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
Int J Cancer
; 149(1): 127-138, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586134
15.
Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis.
Cancer Immunol Immunother
; 70(11): 3207-3216, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33813646
16.
Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?
Radiology
; 298(3): 680-692, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33464183
17.
Serum Bioavailable, Rather Than Total, 25-hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival.
Hepatology
; 72(1): 169-182, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31677282
18.
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients.
BMC Cancer
; 21(1): 775, 2021 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34218801
19.
Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria.
BMC Cancer
; 21(1): 147, 2021 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563246
20.
Surveillance Strategy after Complete Ablation of Initial Recurrent Hepatocellular Carcinoma: A Risk-Based Machine Learning Study.
J Vasc Interv Radiol
; 32(11): 1548-1557.e2, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34474127